Trial Profile
Heme arginate in transplantation - a multi-centre blinded parallel-group randomised trial of heme arginate versus placebo to reduce delayed graft function in kidney transplant recipients. (The HOT 2 Trial).
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 12 Feb 2020
Price :
$35
*
At a glance
- Drugs Haem arginate (Primary)
- Indications Delayed graft function
- Focus Therapeutic Use
- Acronyms The HOT 2 Trial
- 21 Jun 2018 New trial record